OpenAI Reportedly Prepares for IPO Filing Signaling Major Leap for AI Sector Bank of America Projects Fed Rate Cuts Unlikely Until Second Half of 2027 CBS News Report Ford Challenges Tesla and BYD in Europe With Electric Hatchback and SUV Expansion Plan Marvell Technology Stock in Focus Following May 27 Catalyst Recommendation US Races to Establish Ebola Quarantine Facility in Kenya Implications for Global Health Security and Markets UK Egg Prices Surge Why Everyday Essentials Have Become Significantly More Expensive MPLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Gains 147 Plexus Corp PLXS Q1 2026 Earnings EPS Surges Past Estimates on Operational Strength Stock Declines MTVA Q1 2026 Earnings EPS Misses Estimates but Stock Surges 3415 Quantum Biopharma Ltd QNTM Q4 2025 Earnings PreRevenue Biotech Reports Narrowed Loss Shares Rally JEF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions KODK Q1 2026 Earnings A Loss as Revenue Disappears Stock Surges on Thin Data New England Realty Associates NEN Consolidates at 600 Support and Resistance Levels in Focus Pineapple Financial Inc PAPL Gains Nearly 5 as Stock Pushes Toward Resistance Range Capital Acquisition Corp II Warrants RNGTW Holds at 032 as Trading Range Narrows ConnectOne Bancorp Preferred CNOBP Edges Higher as Yield Seeks Support Insteel Industries IIIN Edges Higher Testing Key Resistance Level MindWalk Holdings Corp HYFT Faces Selling Pressure as Price Approaches Key Support Zone Oriental Culture Holding OCG Bounces From Support Eyes Resistance at 192 NVE Corporation NVEC Gains 268 as Technical Levels Signal Potential Upside DCOMP Holds Steady at 1851 Series A Preferred Shares Trade Flat Amid Broad Market Caution Nuveen Preferred Income Opportunities Fund JPC Edges Higher Navigating a YieldDriven Market Pluri Inc PLUR Climbs 322 as Shares Test Resistance Near 249 ONGC Q4 Profit Surges 46 YoY to 10820 Crore Revenue Up 4 Dividend Recommended CFBK Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Travere Therapeutics TVTX Hovers Near Resistance as Slight Dip Tests Support Levels